Approval of Novel TB Drug Celebrated—With Restraint
作者： J. Cohen
DOI: 10.1126/SCIENCE.339.6116.130
关键词: Family medicine 、 Tuberculosis 、 Drug 、 Pharmacology 、 Food and drug administration 、 Medicine 、 Bedaquiline
摘要: The U.S. Food and Drug Administration approved the drug, bedaquiline, for only patients who have multidrug-resistant tuberculosis, which can require up to 2 years of treatment. It is first new tuberculosis drug be green-lighted in more than 40 years, but celebration was tempered as sobering challenges face drug9s wide scale use.
sciencemag.org参考文章(0)